✦ LIBER ✦

PDB27 COST-EFFECTIVENESS OF EXENATIDE VERSUS INSULIN GLARGINE FOR THE TREATMENT OF TYPE-2 DIABETES IN TURKEY: A LONG-TERM HEALTH ECONOMIC ANALYSIS

✍ Scribed by D Bruhn; S Malhan; S Kavuncubasi; J Smith-Palmer; V Reed

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB51 COST-EFFECTIVENESS OF EXENATIDE VE

✍ JL Palmer; CG Pinto; R Duarte; L Miguel; Z Gregor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB27 Projected Cost-Effectiveness of Ex

✍ Wilson, B.P.; Beaudet, A.; Caputo, J.; Timlin, L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PDB9 LONG-TERM CLINICAL OUTCOMES OF EXEN

✍ L Timlin; A Beaudet; B Wilson; D Bruhn; KS Boye; JL Palmer; A Lloyd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Evaluation of exenatide vs. insulin glar

✍ T. Mittendorf; J. Smith-Palmer; L. Timlin; M. Happich; G. Goodall 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

PDB26 Projected Long-Term Clinical and E

✍ Beaudet, A.; Wilson, B.; Caputo, J.; Timlin, L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The cost-effectiveness of insulin glargi

✍ P. Levin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB